Advanced visualization
Combined anatomical and functional imaging insights.
AI for Prostate Cancer Detection
OnQ™ Prostate
Next-Level Prostate Imaging
OnQ™ Prostate
OnQ Prostate is an FDA-cleared software solution powered by Restriction Spectrum Imaging (RSI), a patented diffusion MRI technique shown to improve the detection, in vivo characterization, and localization of clinically significant prostate cancer.
By providing additional insights into prostate tissue, OnQ Prostate supports radiologists in assessing suspicious areas and communicating imaging findings to clinical teams. These insights can help inform further evaluation and treatment planning alongside other clinical information.
Clearer Imaging for
Confident Clinical Decisions
OnQ™ Prostate delivers clear, easy-to-interpret MRI images that support clinical assessment and collaborative decision-making. By improving the visualization and localization of suspicious tissue, it helps guide biopsy targeting and treatment planning. These insights strengthen communication between radiologists and referring physicians across prostate cancer detection, monitoring, and care.
Clearer tissue assessment
Highlight areas of potential clinical significance.
Imaging insights
Quantitative information to support clinical assessment.
OnQ Prostate outputs
Precision in detail.
Clarity in context.
Restricted Signal Map
Highlights areas of restricted diffusion to support closer visual assessment.
Color Fusion Map
Combines restricted signal with T2 imaging for anatomical localization.
Clinical workflow
A connected view of care.
Radiology
Imaging insights to support interpretation.
Urology
Localization to support biopsy planning.
Oncology
Imaging context for coordinated care.
Let’s talk about your workflow
Explore OnQ Prostate
with ARJ Medical.
Discover how quantitative MRI insights could support your team.
